The ocular penetration of beta adrenoceptor blocking drugs a comparative study on atenolol sotalol pindolol metoprolol timolol and propranolol
Ros, F.E.; Innemee, H.C.; Van Zwieten, P.A.
Greve, E L (Ed ) Documenta Ophthalmologica Proceedings Series, Vol 22 Glaucoma Symposium Diagnosis And Therapy; Amsterdam, Netherlands, Sept 1979 Xv+419p Dr W Junk Bv Publishers: The Hague, Netherlands (Dist in The Usa By Kluwer Boston, Inc , Hingham, Mass ) Illus P313-326
1980
Accession: 029388127
Full Text Article emailed within 1 workday: $29.90
Related References
Ros, F.E.; Innemee, H.C.; van Zwieten, P.A. 1980: Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol Documenta Ophthalmologica. Advances in Ophthalmology 48(2): 291-301Egginger, G.; Lindner, W.; Vandenbosch, C.; Massart, D.L. 1993: Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol Biomedical Chromatography: Bmc 7(6): 277-295
Ros, F.E.; Innemee, H.C.; Zwieten, P.A. 1980: Ocular penetration of-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol Documenta Ophthalmologica 48(2): 291-301
Lemmer, B.; Winkler, H.; Ohm, T.; Fink, M. 1985: Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat Naunyn-Schmiedeberg's Archives of Pharmacology 330(1): 42-49
Lemmer, B. 1981: Pharmaco kinetics of beta adrenoceptor blocking drugs of different polarity propranolol metoprolol atenolol in plasma and various organs of the light dark synchronized rat Naunyn-Schmiedeberg's Archives of Pharmacology 316(Suppl): R60
Zaagsma, J.; Meems, L.; Boorsma, M. 1977: Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol Naunyn-Schmiedeberg's Archives of Pharmacology 298(1): 29-36
Jean De Crée; Hedwig Geukens; Jos Leempoels; Herman Verhaegen 1986: Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta-1-adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol Drug Development Research 8(1-4): 109-117
D.C.ee J.; Geukens, H.; Leempoels, J.; Verhaegen, H. 1986: Hemodynamic effects in man during exercise of a single oral dose of narbivolol r 67555 a new beta 1 adrenoceptor blocking agent a comparative study with atenolol pindolol and propranolol Drug Development Research 8(1-4): 109-118
Orekhov, A.N.; Andrianova, I.V.; Rekhter, M.D.; Tertov, V.V.; Andreeva, E.R.; Ragimov, S.E.; Mironov, A.A. 1992: Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine Atherosclerosis 95(1): 77-85
Harms, H.H.; Spoelstra, A.J. 1978: Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog Clinical and Experimental Pharmacology and Physiology 5(1): 53-59
Salimi, M. 1975: Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle Pharmacology 13(5): 441-447
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Svendsen, T.L.; Trap-Jensen, J.; Carlsen, J.E.; McNair, A. 1985: Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease American Heart Journal 109(5 Part 2): 1145-1150
Svendsen, T.L.; Trap Jensen, J.; Carlsen, J.E.; Mcnair, A. 1985: Immediate central hemodynamic effects of 5 different beta adrenoceptor blocking agents acebutolol atenolol pindolol practolol and propranolol in patients with ischemic heart disease American Heart Journal 109(5 Part 2): 1145-1150
Hellenbrecht, D.; Enenkel, J. 1976: Estimation of the nonspecific cardio depressant potency of beta adrenergic blocking drugs propranolol pindolol practolol and atenolol Naunyn-Schmiedeberg's Archives of Pharmacology 293(Suppl): R22
Mucklow, J.C.; Kuhn, S. 1984: The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers European Journal of Clinical Pharmacology 27(3): 269-273
Richer, C.; Maury, M.; Poirier, J.M.; Duhaze, P.; Giudicelli, J.F. 1982: Comparative beta-adrenoceptor blocking effects and pharmacokinetics of sotalol and propranolol in healthy volunteers Therapie 37(3): 259-267
Von Wichert, P.; Boes, J. 1979: Beta-receptor blocking drugs and the bronchial system. a comparative study of pindolol and metoprolol Medizinische Klinik 74(42): 1544-1547
Burris, J.F.; Goldstein, J.; Zager, P.G.; Sutton, J.M.; Sirgo, M.A.; Plachetka, J.R. 1986: Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol Journal of Clinical Hypertension 2(3): 285-293
Erikssen, J.; Thaulow, E.; Mundal, R.; Opstad, P.; Nitter-Hauge, S. 1982: Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol) British Journal of Clinical Pharmacology 13(Suppl 2): 201s-209s